Contact a Pharmaceutical Attorney Get a free case evaluation by a qualified attorney. Enter Your City: Enter Your State: Select Your State Alaska Alabama Arkansas American Somoa Arizona California Colorado Connecticut District of Columbia Delaware Florida Georgia Hawaii Iowa Idaho Illinois Indiana Kansas Kentucky Louisiana Massachusetts Maryland Maine Marshall Islands Michigan Minnesota Missouri Mississippi Montana North Carolina North Dakota Nebraska New Hampshire New Jersey New Mexico Nevada New York Ohio Oklahoma Oregon Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah Virginia US Virgin Islands Vermont Washington Wisconsin West Virginia Wyoming Outside US

Plavix, the so-called super aspirin that has been touted as better than aspirin in preventing heart attacks and strokes, has not proven itself to be effective in recent studies. Plavix, which costs hundreds of times more than aspirin, has not outperformed simple aspirin in most patient groups. In fact, it has been linked to risks of death from gastrointestinal hemorrhage.

Suffered harm from Plavix? You may have a lawsuit. Click here, for a top rated law firm to evaluate your legal rights.

A study released in the March 2006 meeting of the American College of Cardiology concluded that the costs and risks of Plavix are too great to recommend its use. The study was funded by the Plavix manufacturer, the Paris-based Sanofi Synthelabo, which hoped to double revenues by showing the effectiveness of Plavix.

Dr. Deepack Bhatt of the Cleveland Clinic headed the study of 15,603 people in 32 countries. The study found that Plavix did not reduce the risk of heart attacks or strokes in most groups as compared to aspirin. There was a slight improvement with Plavix use in patients who had established heart disease, but not enough to prove effectiveness without further study. The improvement in this group was counterbalanced by an increased risk of death from hemorrhage. In patients without a history of heart disease, heart-related deaths almost doubled after using Plavix.

This study is consistent with a study published in the January 20, 2005 issue of the New England Journal of Medicine, which found that patients taking Plavix had 12 times more ulcers than those taking aspirin with a heartburn medicine. This finding was significant, since both the American College of Cardiology and the American Heart Association had recommended the expensive Plavix, because they believed it caused fewer ulcers than aspirin.

If you or a loved one is using Plavix, you might want to consult your health care provider about the likelihood of side effects. If you have already been injured by using Plavix, you should have your case evaluated by a competent Plavix attorney. See Plavix Attorney and Lawyer – How to Hire to find out how to find one.

Check out the following articles for more information about Plavix, filing a Plavix lawsuit and finding a Plavix attorney.

• For more information about Plavix, see Drug Overview: Plavix Side Effects and Claims.
• For more information about Plavix side effects, see Plavix Side Effects.
• To find out more about the FDA warning, see Plavix Side Effects and Risks.
• If you would like to learn more about Plavix lawsuits, see Plavix Lawsuits, Litigation & Lawyers.
• To learn more about Plavix attorneys and how to find one, see Hiring a Plavix Attorney and Lawyer.

Suffered harm from Plavix? You may have a lawsuit. Click here, for a top rated law firm to evaluate your legal rights.